284 related articles for article (PubMed ID: 22894616)
1. Detection of gram-negative β-lactamase producing pathogens in the clinical lab.
Thomson KS
Curr Pharm Des; 2013; 19(2):250-6. PubMed ID: 22894616
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections.
Rameshkumar G; Ramakrishnan R; Shivkumar C; Meenakshi R; Anitha V; Venugopal Reddy YC; Maneksha V
Indian J Ophthalmol; 2016 Apr; 64(4):303-11. PubMed ID: 27221683
[TBL] [Abstract][Full Text] [Related]
3. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
[TBL] [Abstract][Full Text] [Related]
4. β-lactam susceptibility in extended-spectrum β-lactamase-producing isolates.
Agrawal GN; Rahangdale HD; Walawalkar AW
Indian J Pathol Microbiol; 2017; 60(1):142-143. PubMed ID: 28195120
[No Abstract] [Full Text] [Related]
5. β-lactam resistance in gram-negative pathogens isolated from animals.
Trott D
Curr Pharm Des; 2013; 19(2):239-49. PubMed ID: 22894614
[TBL] [Abstract][Full Text] [Related]
6. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control.
Stürenburg E; Mack D
J Infect; 2003 Nov; 47(4):273-95. PubMed ID: 14556752
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
9. Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia.
Tekele SG; Teklu DS; Tullu KD; Birru SK; Legese MH
PLoS One; 2020; 15(11):e0241984. PubMed ID: 33180785
[TBL] [Abstract][Full Text] [Related]
10. Emerging epidemic of metallo-beta-lactamase-mediated resistances.
Jones RN; Biedenbach DJ; Sader HS; Fritsche TR; Toleman MA; Walsh TR
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):77-84. PubMed ID: 15698711
[No Abstract] [Full Text] [Related]
11. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
Shah AA; Hasan F; Ahmed S; Hameed A
Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
[TBL] [Abstract][Full Text] [Related]
12. Potential involvement of beta-lactamase homologous proteins in resistance to beta-lactam antibiotics in gram-negative bacteria of the ESKAPEE group.
de Souza J; Vieira AZ; Dos Santos HG; Faoro H
BMC Genomics; 2024 May; 25(1):508. PubMed ID: 38778284
[TBL] [Abstract][Full Text] [Related]
13. Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria.
Yusuf I; Arzai AH; Haruna M; Sharif AA; Getso MI
Braz J Microbiol; 2014; 45(3):791-8. PubMed ID: 25477909
[TBL] [Abstract][Full Text] [Related]
14. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
Ko WC; Hsueh PR
J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
[TBL] [Abstract][Full Text] [Related]
15. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
Hrabák J
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
[TBL] [Abstract][Full Text] [Related]
16. Metallo-β-lactamases: a last frontier for β-lactams?
Cornaglia G; Giamarellou H; Rossolini GM
Lancet Infect Dis; 2011 May; 11(5):381-93. PubMed ID: 21530894
[TBL] [Abstract][Full Text] [Related]
17. Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study.
Juan C; Conejo MC; Tormo N; Gimeno C; Pascual Á; Oliver A
J Antimicrob Chemother; 2013 Mar; 68(3):619-30. PubMed ID: 23143898
[TBL] [Abstract][Full Text] [Related]
18. Detection of expanded-spectrum β-lactamases in Gram-negative bacteria in the 21st century.
Al-Bayssari C; Dabboussi F; Hamze M; Rolain JM
Expert Rev Anti Infect Ther; 2015; 13(9):1139-58. PubMed ID: 26162631
[TBL] [Abstract][Full Text] [Related]
19. New β-lactam antibiotics and β-lactamase inhibitors.
Bush K; Macielag MJ
Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927
[TBL] [Abstract][Full Text] [Related]
20. [Study on prevalence and molecular mechanisms of antibacterial resistance in Gram-negative pathogens of nosocomial infections in hospitals of Moscow and Perm'].
Mudrak DE; Ikriannikova LN; Sidorenko SV; Il'ina EN
Antibiot Khimioter; 2007; 52(7-8):10-6. PubMed ID: 18986019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
